Research articlePublished 15 Dec 2020
Validated RP-HPLC Method Development of Pazopanib in Bulk and its Pharmaceutical Dosage Form
Abstract
Objectives: An accurate, sensitive, precise and rapid method for analysis and quantification of Pazopanib by Reverse Phase High Performance Chromatography (RP-HPLC) was developed and validated. Pazopanib in bulk and formulations were analyzed and quantification. Methods: Pazopanib in bulk and formulations were analyzed on Phenomenex enable C18 column (15x4.6mm, 5μm particle size) as stationary phase. Mobile phase was composed of acetonitrile and phosphate buffer (pH 5) in the ratio of 60:40%v/v at a flow rate of 1.2ml/min. elutes were analyzed using PDA detector at a detection wavelength of 290nm. The proposed method was validated by ICH guidelines, Validation of Analytical Procedures: Text and Methodology Q2 (R1). Results: In this study, the chromatographic peaks of Pazopanib showed good resolution with retention time of 2.190min. Pazopanib showed an excellent linearity with 0.998 of correlation coefficient. Other validation parameters including precision, specificity, accuracy and robustness demonstrated good reliability in the quantification of Pazopanib.
Subjects
Pharmaceutical SciencesFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Methods
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kiran Kumar Buralla”
- BylineArticles whose byline prints “Varadarajan Parthasarathy”